Usana Health Sciences (USNA) Short-Term Debt issuances (2016 - 2025)
Historic Short-Term Debt issuances for Usana Health Sciences (USNA) over the last 9 years, with Q2 2025 value amounting to $1.6 million.
- Usana Health Sciences' Short-Term Debt issuances rose 93896.1% to $1.6 million in Q2 2025 from the same period last year, while for Sep 2025 it was $24.6 million, marking a year-over-year increase of 156090.48%. This contributed to the annual value of $23.7 million for FY2024, which is 143612.19% up from last year.
- Per Usana Health Sciences' latest filing, its Short-Term Debt issuances stood at $1.6 million for Q2 2025, which was up 93896.1% from $23.0 million recorded in Q4 2024.
- Usana Health Sciences' 5-year Short-Term Debt issuances high stood at $23.0 million for Q4 2024, and its period low was -$60.0 million during Q1 2022.
- Over the past 4 years, Usana Health Sciences' median Short-Term Debt issuances value was $537000.0 (recorded in 2024), while the average stood at -$2.0 million.
- The largest annual percentage gain for Usana Health Sciences' Short-Term Debt issuances in the last 5 years was 280378.79% (2024), contrasted with its biggest fall of 7946.67% (2024).
- Usana Health Sciences' Short-Term Debt issuances (Quarter) stood at $500000.0 in 2022, then skyrocketed by 58.4% to $792000.0 in 2023, then soared by 2803.79% to $23.0 million in 2024, then tumbled by 93.04% to $1.6 million in 2025.
- Its Short-Term Debt issuances was $1.6 million in Q2 2025, compared to $23.0 million in Q4 2024 and -$2000.0 in Q3 2024.